Dickson Robert P, Erb-Downward John R, Freeman Christine M, Walker Natalie, Scales Brittan S, Beck James M, Martinez Fernando J, Curtis Jeffrey L, Lama Vibha N, Huffnagle Gary B
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, United States of America; Research Service, Department of Veterans Affairs Health Care System, Ann Arbor, Michigan, United States of America.
PLoS One. 2014 May 15;9(5):e97214. doi: 10.1371/journal.pone.0097214. eCollection 2014.
Multiple independent culture-based studies have identified the presence of Pseudomonas aeruginosa in respiratory samples as a positive risk factor for bronchiolitis obliterans syndrome (BOS). Yet, culture-independent microbiological techniques have identified a negative association between Pseudomonas species and BOS. Our objective was to investigate whether there may be a unifying explanation for these apparently dichotomous results.
We performed bronchoscopies with bronchoalveolar lavage (BAL) on lung transplant recipients (46 procedures in 33 patients) and 26 non-transplant control subjects. We analyzed bacterial communities in the BAL fluid using qPCR and pyrosequencing of 16S rRNA gene amplicons and compared the culture-independent data with the clinical metadata and culture results from these subjects.
Route of bronchoscopy (via nose or via mouth) was not associated with changes in BAL microbiota (p = 0.90). Among the subjects with positive Pseudomonas bacterial culture, P. aeruginosa was also identified by culture-independent methods. In contrast, a distinct Pseudomonas species, P. fluorescens, was often identified in asymptomatic transplant subjects by pyrosequencing but not detected via standard bacterial culture. The subject populations harboring these two distinct pseudomonads differed significantly with respect to associated symptoms, BAL neutrophilia, bacterial DNA burden and microbial diversity. Despite notable differences in culturability, a global database search of UM Hospital Clinical Microbiology Laboratory records indicated that P. fluorescens is commonly isolated from respiratory specimens.
We have reported for the first time that two prominent and distinct Pseudomonas species (P. fluorescens and P. aeruginosa) exist within the post-transplant lung microbiome, each with unique genomic and microbiologic features and widely divergent clinical associations, including presence during acute infection.
多项基于培养的独立研究已确定呼吸道样本中存在铜绿假单胞菌是闭塞性细支气管炎综合征(BOS)的阳性风险因素。然而,非培养微生物技术已确定假单胞菌属与BOS之间存在负相关。我们的目的是研究对于这些明显矛盾的结果是否可能存在一个统一的解释。
我们对肺移植受者(33例患者进行了46次操作)和26名非移植对照受试者进行了支气管镜检查及支气管肺泡灌洗(BAL)。我们使用16S rRNA基因扩增子的qPCR和焦磷酸测序分析了BAL液中的细菌群落,并将非培养数据与这些受试者的临床元数据和培养结果进行了比较。
支气管镜检查途径(经鼻或经口)与BAL微生物群的变化无关(p = 0.90)。在假单胞菌细菌培养阳性的受试者中,通过非培养方法也鉴定出了铜绿假单胞菌。相比之下,通过焦磷酸测序在无症状移植受试者中经常鉴定出一种独特的假单胞菌——荧光假单胞菌,但通过标准细菌培养未检测到。携带这两种不同假单胞菌的受试者群体在相关症状、BAL中性粒细胞增多、细菌DNA负荷和微生物多样性方面存在显著差异。尽管可培养性存在显著差异,但对UM医院临床微生物学实验室记录的全球数据库搜索表明,荧光假单胞菌通常从呼吸道标本中分离出来。
我们首次报告,移植后肺微生物群中存在两种突出且不同的假单胞菌(荧光假单胞菌和铜绿假单胞菌),每种都具有独特的基因组和微生物学特征以及广泛不同的临床关联,包括在急性感染期间的存在情况。